Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice

Gene Therapy

Volumn 11, Issue 3, 2004, Pages 317-324

  Sakamoto, T ^a   Miyazaki, E ^a   Aramaki, Y ^a   Arima, H ^a,c   Takahashi, M ^a   Kato, Y ^b   Koga, M ^b   Tsuchiya, S ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotides; Atopic dermatitis; Interleukin 10; NC Nga mice; Topical

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BIOSYNTHESIS; CONTROLLED STUDY; DERMIS; DISEASE MODEL; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG PENETRATION; DRUG STABILITY; EPIDERMIS; GENE THERAPY; GENETICS; IMMUNOLOGY; IONTOPHORESIS; MALE; METABOLISM; METHODOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATHOLOGY; PRIORITY JOURNAL; SKIN; SKIN ABSORPTION; SKIN DEFECT; SKIN PENETRATION; TREATMENT OUTCOME;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; GENE THERAPY; IMMUNOGLOBULIN E; INTERLEUKIN-10; IONTOPHORESIS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SKIN; SKIN ABSORPTION;

ANIMALIA;

EID: 1242341265     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302171     Document Type: Article

References (36)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-137.
2. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998; 351: 1715-1721.
3. Soter NA. Morphology of atopic eczema. Allergy 1989; 44 (Suppl 9): 16-19.
4. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990; 15: 264-266.
5. Grewe M et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-361.
6. Pastore S et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997; 99: 3009-3017.
7. Ying S et al. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protem-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macropbage recruitment. J Exp Med 1995; 181: 2153-2159.
8. Ohmen JD et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154: 1956-1963.
9. Vestergaard C et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999; 104: 1097-1105.
10. Vestergaard C et al. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J Dermatol Sci 2001; 26: 46-54.
11. Cohen SB et al. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 1997; 92: 1-5.
12. Orteu CH et al. The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema. Clin Exp Immunol 2000; 122: 150-156.
13. Akdis M et al. Cytokine network and dysregulated apoptosis in atopic dermatitis. Acta Odontol Scand 2001; 59: 178-182.
14. Matsuda H et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9: 461-466.
15. Vestergaard C, Yoneyama H, Matsushima K. The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 2000; 6: 209-210.
16. Matsumoto M et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 1999; 162: 1056-1063.
17. Agrawal S, Zhao Q. Antisense therapeutics. Curr Opin Chem Biol 1998; 2: 519-528.
18. Crooke ST. Antisense therapeutics. Biotechnol Genet Eng Rev 1998; 15: 121-157.
19. Arima H et al. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 1998; 8: 319-327.
20. Merino V, Kalia YN, Guy RH. Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol 1997; 15: 288-290.
21. Guy RH. Iontophoresis - recent developments. J Pharm Pharmacol 1998; 50: 371-374.
22. Regnier V, Preat V. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res 1998; 15: 1596-1602.
23. Kay AB et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775-778.
24. Regnier V, De Morre N, Jadoul A, Preat V. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm 1999; 184: 147-156.
25. Brand RM, Hannah TL, Norris J, Iversen PL. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo. Antisense Nucleic Acid Drug Dev 2001; 11: 1-6.
26. Anigbogu A et al. An in vivo investigation of the rabbit skin responses to transdermal iontophoresis. Int J Pharm 2000; 200: 195-206.
27. Burnette RR, Ongpipattanakul B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci 1988; 77: 132-137.
28. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96: 302-318; quiz 319.
29. Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983; 71: 47-56.
30. Novak N, Bieber T, Katoh N. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001; 167: 797-804.
31. Nakagawa H et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344: 883.
32. Hiroi J et al. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 1998; 76: 175-183.
33. Nakamura H et al. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Therapy 2002; 9: 1221-1229.
34. Kakinuma T et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-541.
35. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001; 24: 382-389.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.